Evidence map›Paper›PMID 30955065›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2019

Protective and therapeutic effects of milrinone on acoustic trauma in rat cochlea.

Seyit Mehmet Ceylan, Erdal Uysal, Serdar Altinay, Efe Sezgin, Nagihan Bilal, Emine Petekkaya, Mehmet Dokur, Mahmut Alper Kanmaz, Mustafa Emre Gulbagci

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Seyit Mehmet CeylanDepartment of Otorhinolaryngology, Faculty of Medicine, Sanko University, Incilipinar Mah. Ali Fuat Cebesoy Bulv. No: 45, Gaziantep, Turkey. drmehmetceylan@hotmail.com.ORCID http://orcid.org/0000-0002-8908-3345
Erdal UysalDepartment of General Surgery, Faculty of Medicine, Sanko University, Gaziantep, Turkey.
Serdar AltinayDepartment of Pathology, Bakırköy Dr Sadi Konuk Health Application and Research Center, Istanbul, Turkey.
Efe SezginLaboratory of Nutrigenomics and Epidemiology, Department of Food Engineering, Izmir Institute of Thecnology, Izmir, Turkey.
Nagihan BilalDepartment of Otorhinolaryngology, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey.
Emine PetekkayaDepartment of Anatomy, Faculty of Medicine, Beykent University, Istanbul, Turkey.
Mehmet DokurDepartment of Emergency Medicine, Faculty of Medicine, Biruni University, Istanbul, Turkey.
Mahmut Alper KanmazDepartment of Otorhinolaryngology, Faculty of Medicine, Sanko University, Incilipinar Mah. Ali Fuat Cebesoy Bulv. No: 45, Gaziantep, Turkey.
Mustafa Emre GulbagciDepartment of Pathology, Bakırköy Dr Sadi Konuk Health Application and Research Center, Istanbul, Turkey.
Sanko University · TRBakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi · TRBeykent University · TRBiruni University · TRIzmir Institute of Technology · TRKahramanmaraş Sütçü İmam University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to investigate the potential protective and therapeutic effects of milrinone, a specific phosphodiesterase (PDE) III inhibitor, on acoustic trauma-induced cochlear injury and apoptosis.

methodsA total number of 30 healthy Wistar albino rats were evenly divided into five groups as follows: group 1 was assigned as control group; group 2 and 3 were assigned as low-dosage groups (0.25 mg/kg) in which milrinone was administered 1 h before acoustic trauma (AT) and 2 h after AT, respectively; group 4 and 5 were assigned as high-dosage groups (0.50 mg/kg) in which the drug was administered 1 h before AT and 2 h after AT, respectively. Except control group, all treatment groups received a single dosage of milrinone for 5 days. Distortion product otoacoustic emissions (DPOAE) measurements were recorded before AT as well as at second and fifth post-traumatic days. At the end of fifth day, all rats were sacrificed and the cochlea of the rats was removed for histopathological evaluation. In addition, the groups were compared in terms of apoptotic index via caspase-3 staining.

resultsIn terms of signal-to-noise ratio (SNR), there was no statistically significant difference among the groups following AT (p > 0.05). After 5 days of milrinone treatment, the best SNR values were found in group 5, though all groups did not statistically differ (p > 0.05). In histopathological evaluation, vacuolization, inflammation, and edema scores in all treatment groups were statistically lower than those of the control group (p < 0.05). In group 2 and 4 where the drug was administered before AT, the inflammation and apoptosis index was lower than those of group 3 and 5 where the drug was administered after AT (p < 0.0001).

conclusionWe reveal that milrinone has a protective effect on cochlear damage in the experimental acoustic model of rats. This protective effect was more apparent following the pre-traumatic milrinone administration, and is associated with its effect on decreasing inflammation and apoptosis. Based on DPOAE measurements following AT, especially in the group 5 (high-dosage group), milrinone may also have a therapeutic effect.

Indexed as

Hearing Loss, Noise-InducedAnimalsApoptosisAudiometryCochleaMaleMilrinonePhosphodiesterase 3 InhibitorsRatsRats, WistarTreatment OutcomeMilrinonePhosphodiesterase 3 InhibitorsAcoustic traumaApoptosisCaspase 3Hearing lossInner earMilrinone

Identifiers

PMID30955065
OpenAlexW2932374007

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.